Milestone Scientific Inc. (MLSS) News
Track canonical SquawkNews coverage tagged to MLSS, Milestone Scientific Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 12 indexed stories across 8 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
Milestone Scientific Inc. (MLSS) Details CompuFlo Scaling Strategy
Milestone Scientific outlined a plan to scale CompuFlo, citing growing physician use, initial Medicare payment access under CPT 0777T in select MACs, expanded sales coverage, and supportive clinical data.Material Details
NEWS | Sep 29, 2026, 12:38 PM UTC
L
Milestone Scientific Highlights Building a Scalable Growth Platform for CompuFlo® Medical Business
CompuFlo Builds Momentum as Physician Adoption, Reimbursement Access, Commercial Coverage and Clinical Evidence ExpandROSELAND, N.J., Sept. 29, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE American: MLSS), a
NEWS | Sep 29, 2026, 12:32 PM UTC
L
MLSS - Milestone Scientific Announces Pain and Spine Specialists and Dr. Sudhir Rao as CompuFlo® Development Partner and Advisor
MLSS - Milestone Scientific Announces Pain and Spine Specialists and Dr. Sudhir Rao as CompuFlo® Development Partner and Advisor
NEWS | Sep 16, 2026, 01:00 PM UTC
L
Milestone Scientific debt-to-equity conversion makes balance sheet debt-free
Milestone Scientific says three directors converted debt to equity, resulting in a debt-free balance sheet.
EQUITY | Aug 26, 2026, 01:01 PM UTC
L
Milestone Scientific shares fall after Q2 results, Q3 sales guidance
Milestone Scientific (MLSS) is trading lower after it reported Q2 financial results and issued Q3 sales guidance below analyst estimates.
EARNINGS | Aug 14, 2026, 04:53 PM UTC
L
Milestone Scientific affirms FY2026 sales guidance at $9.8M-$10.2M
Milestone Scientific (AMEX: MLSS) affirms FY2026 sales outlook of $9.800 million-$10.200 million, unchanged, versus a $9.910 million estimate.
EARNINGS | Aug 14, 2026, 02:40 PM UTC
L
Milestone Scientific reports Q2 revenue up 22% to $2.8 million
Milestone Scientific said second-quarter revenue rose 22% to $2.8 million, with medical segment revenue up 231% and 2026 revenue guidance reaffirmed at $9.8 million to $10.2 million.
EARNINGS | Aug 14, 2026, 01:10 PM UTC
L
Milestone Scientific reports Q2 2026 financial results
Milestone Scientific (MLSS) reports financial results for its second quarter 2026, according to TradeXchange Newsdesk, with no additional figures provided in the feed.
EARNINGS | Aug 14, 2026, 11:30 AM UTC
L
MLSS - Milestone Scientific Schedules Second Quarter 2026 Financial Results Conference Call
MLSS - Milestone Scientific Schedules Second Quarter 2026 Financial Results Conference Call
EARNINGS | Aug 06, 2026, 12:47 PM UTC
M
Milestone Scientific Expands CompuFlo Access
Milestone partners with Red One Medical
EQUITY | Aug 04, 2026, 12:31 PM UTC
L
Milestone Scientific Expects Q2 Revenue Of ~$2.8M, Up 21% YoY; H1 Revenue Of ~$5M, Up 9% YoY
Milestone Scientific Inc. (NYSE: MLSS ), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced preliminary, unaudited revenue for the second quarter e
EARNINGS | Jul 01, 2026, 12:35 PM UTC
M
MLSS Appoints Directors
Milestone Scientific appoints two independent directors and transitions chair to executive chair to drive strategic execution
EQUITY | Jun 25, 2026, 01:00 PM UTC